News.
Stay up to date with the latest news about our innovation initiatives
Published on 20/05/2022
Innovative therapies for vitiligo
Almirall and Inserm Transfert enter into a licensing and research collaboration to develop innovative treatments for vitiligo
Almirall announces a collaboration with the University of Michigan to gain understanding of disease drivers in hidradenitis suppurativa
Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases
Almirall is looking for new assets that could be used for the treatment of skin conditions such as immune-inflammatory, dermato-oncology, and rare diseases
Almirall joins BIOMAP (Biomarkers in Atopic Dermatitis and Psoriasis) as a new partner
